<code id='6382A1C888'></code><style id='6382A1C888'></style>
    • <acronym id='6382A1C888'></acronym>
      <center id='6382A1C888'><center id='6382A1C888'><tfoot id='6382A1C888'></tfoot></center><abbr id='6382A1C888'><dir id='6382A1C888'><tfoot id='6382A1C888'></tfoot><noframes id='6382A1C888'>

    • <optgroup id='6382A1C888'><strike id='6382A1C888'><sup id='6382A1C888'></sup></strike><code id='6382A1C888'></code></optgroup>
        1. <b id='6382A1C888'><label id='6382A1C888'><select id='6382A1C888'><dt id='6382A1C888'><span id='6382A1C888'></span></dt></select></label></b><u id='6382A1C888'></u>
          <i id='6382A1C888'><strike id='6382A1C888'><tt id='6382A1C888'><pre id='6382A1C888'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:427
          Person wearing a blue glove holding money against a blue backdrop.
          Adobe

          WASHINGTON — Medicare officials are moving forward with a plan to claw back money from certain hospitals to try to remedy overpayments struck down by the Supreme Court, they announced Thursday.

          A federal court ordered the Department of Health and Human Services to compensate hospitals that receive discounted drugs through the 340B program for billions of dollars of underpayments, but the money had already gone out to hospitals that didn’t participate in the program.

          advertisement

          Medicare is planning to send $9 billion in lump-sum payments to more than 1,600 hospitals that participate in the drug discount program after the Supreme Court found the program underpaid them for prescription drugs, the agency announced on Friday.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          George Santos makes 1st court appearance after pleading not guilty to 13 counts
          George Santos makes 1st court appearance after pleading not guilty to 13 counts

          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

          read more
          European regulators consider appeal over Amylyx ALS drug
          European regulators consider appeal over Amylyx ALS drug

          PauloAmorim/VWPicsviaAPImagesLONDON—Thisweek,EuropeanregulatorsareconsideringanappealfromAmylyxPharm

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Life sciences deals on track to hit lowest point since 2017

          AdobeIt’snosecretthatbiotechindustryfundinghasfallenfromitsCovidhighs.Butwithjustafewmonthsleftinthe